|
87
|
301
|
9mvqA |
Crystal structure of sars-cov-2 main protease (mpro) variant q192t in complex with inhibitor avi-4303 |
|
91
|
305
|
9mvoA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with inhibitor avi-4692 |
|
77
|
305
|
9mvpA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-4516 |
|
76
|
302
|
9m2vA |
Crystal structure of the sars-cov-2 (covid-19) main protease with inhibitor mc12 |
|
84
|
296
|
9kgqA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
81
|
299
|
9kgnA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
79
|
298
|
9kgjA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
83
|
302
|
9kgsA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
92
|
307
|
9kgrA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
108
|
504
|
9js7A |
Cryoem of antibody complexed with mature zika virus |
|
235
|
926
|
9immA |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
248
|
926
|
9imkA |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
171
|
592
|
9immE |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
180
|
592
|
9imkE |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
17
|
113
|
9immG |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
17
|
113
|
9imkG |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
48
|
187
|
9immB |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
47
|
187
|
9imkB |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
192
|
592
|
9i53A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with atp |
|
196
|
592
|
9i51A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with adp |
|
84
|
304
|
9hfxA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097558 |
|
87
|
303
|
9hfyA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097078 |
|
74
|
286
|
9fwsB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00258 |
|
71
|
286
|
9fwhB |
Crystal structure of sars-cov-2 nsp10-exon in complex with vt00019 |
|
69
|
285
|
9fwpB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00198 |
|
70
|
285
|
9fwrB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00249 |
|
74
|
286
|
9fwmB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00180 |
|
71
|
286
|
9fwiB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00025 |
|
71
|
285
|
9fwqB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00218 |
|
69
|
285
|
9fwoB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00216 |
|
72
|
286
|
9fwnB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00219 |
|
71
|
286
|
9fwkB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00123 |
|
69
|
285
|
9fwjB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00079 |
|
70
|
286
|
9fwlB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00167 |
|
74
|
285
|
9fwuB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00421 |
|
74
|
286
|
9fwtB |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00259 |
|
88
|
301
|
9ddfA |
Sars-cov-2 main protease with inhibitor |
|
89
|
302
|
9ddgA |
Sars-cov-2 main protease with inhibitor |
|
86
|
301
|
9cjuA |
Structure of sars-cov-2 main protease in complex with bofutrelvir in orthorhombic form |
|
83
|
301
|
9cjtA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with bofutrelvir |
|
83
|
303
|
9cjvA |
X-ray crystal structure of sars-cov-2 main protease complex with bofutrelvir |
|
83
|
303
|
9cjpA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with nirmatrelvir |
|
83
|
301
|
9cjsA |
X-ray crystal structure of sars-cov-2 main protease triple mutants in complex with bofutrelvir |
|
76
|
301
|
9cjoA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants |
|
84
|
305
|
9cjqA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with ensitrelvir |
|
86
|
300
|
9cjrA |
X-ray crystal structure of sars-cov-2 main protease double mutants in complex with ensitrelvir |
|
96
|
315
|
9bf7A |
Sars-cov-2 papain-like protease (plpro) c111s untagged crystal structure |
|
67
|
391
|
9b6xA |
Envelope protein asu of yfv-asibi with yfv-17d diii |
|
62
|
391
|
9b6uA |
Envelope protein asu of yfv-17d in complex with 2c9 fab |
|
93
|
315
|
8xtdA |
Sars-cov-2 papain-like-protease (plpro) in complex with inhibitor linagliptin |
